Bioxyne Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bioxyne Limited with three other
companies in this sector in Australia:
Prima Biomed Limited
sales of 2.03 million Australian Dollars [US$1.52 million]
of which 87%
was Cancer Immunotherapy),
Silex Systems Ltd
(1.62 million Australian Dollars [US$1.21 million]
Innate Immunotherapeutics Ltd
(2.29 million Australian Dollars [US$1.72 million]
During the year ended June of 2016, sales at
Bioxyne Limited were A$1.98 million (US$1.48 million).
increase of 31.9%
versus 2015, when the company's sales were A$1.50 million.
Despite this increase, sales are still
below the level achieved in 2014, when Bioxyne Limited
reported sales of A$2.31 million.